Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis AG Stock Buy Recommendation Reiterated (NVS)
The Street
Friday, May 24, 2013 - 11:10am
tags:
Novartis
Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting
Forbes
Friday, May 24, 2013 - 11:08am
tags:
Avandia, type 2 diabetes, diabetes, GSK, FDA, Steve Nissen
Pfizer Has Potential To Grow Despite Decreasing Sales
Seeking Alpha
Friday, May 24, 2013 - 11:06am
tags:
Pfizer
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments
Forbes
Friday, May 24, 2013 - 11:05am
tags:
Steve Nissen, GSK, Avandia, type 2 diabetes, diabetes
Unclear Future for Merck's Insomnia Drug
Motley Fool
Friday, May 24, 2013 - 11:02am
tags:
Merck, suvorexant, insomnia, sleep aid
Impax Launches Generic Zomig
Yahoo/Zacks
Friday, May 24, 2013 - 11:00am
tags:
Impax Laboratories, Zomig, generics
Merck ends development of Parkinson's disease drug
Yahoo/AP
Friday, May 24, 2013 - 10:59am
tags:
Parkinson's Disease, Preladenant, Merck
Why This Obesity Drug Is the Sector's Best Bet
Motley Fool
Friday, May 24, 2013 - 10:49am
tags:
Arena, Belviq, obesity, weight loss
Strong Drug Performance Boosts Santarus Higher
Forbes
Friday, May 24, 2013 - 10:48am
tags:
Santarus, Cycloset, diabetes, type 2 diabetes
Biotech Stock Mailbag: Amarin, MannKind, Palatin
The Street
Friday, May 24, 2013 - 10:45am
tags:
Amarin, MannKind, Palatin
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic for Beta-thalassemia
Yahoo/PR NewsWire
Friday, May 24, 2013 - 10:44am
tags:
Sangamo BioSciences, beta-thalassemia, stem cells, ZFP Therapeutic
China Biologic Comments on the Proposed Shanghai RAAS Transaction
Yahoo/PR NewsWire
Friday, May 24, 2013 - 10:42am
tags:
China Biologic
Novo obesity drug could launch in U.S. end 2014
Reuters
Friday, May 24, 2013 - 10:40am
tags:
Novo Nordisk, liraglutide, obesity, weight loss
Vivus Heats Up, Shorts Discouraged On Possible Bidding War
Seeking Alpha
Friday, May 24, 2013 - 10:38am
tags:
Vivus
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Yahoo/BusinessWire
Friday, May 24, 2013 - 10:37am
tags:
Astellas, Medivation, Enzalutamide, prostate
Arena - Good Sales, Bad Sales, Long And Short
Seeking Alpha
Friday, May 24, 2013 - 10:34am
tags:
Arena Pharmaceutical
3 Pipeline Obesity Treatments You Should Watch
Motley Fool
Thursday, May 23, 2013 - 12:03pm
tags:
obesity, Vivus, Orexigen, Contrave, Belviq, tesofensine, Neurosearch, Qsymia, Arena Pharmaceuticals
Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability
Seeking Alpha
Thursday, May 23, 2013 - 11:57am
tags:
Belviq, obesity, Arena Pharmaceuticals, off-label
Royalty Pharma eases condition for Elan offer
Yahoo/AP
Thursday, May 23, 2013 - 11:53am
tags:
Royalty Pharma, Elan, M&A
Ranbaxy said to be eyeing major cuts to sales force, mainly in U.S.
Fierce Pharma
Thursday, May 23, 2013 - 11:52am
tags:
Ranbaxy, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.